Chip Appelbaum

Chip Appelbaum, often referred to as "Chip," is the President and CEO of Novian Health, a company that specializes in developing innovative medical technologies, particularly a laser-based system for tumor treatment. Under his leadership, Novian Health has made significant advancements, including obtaining CE Mark approval in Europe for treating both benign and malignant breast tumors and transitioning from a Premarket Approval (PMA) to a 510(k) pathway with the FDA for benign tumors.13

Chip has a strong educational background, holding an MBA from The University of Chicago Booth School of Business and a Master of Science in Chemical Engineering from the Massachusetts Institute of Technology (MIT) .25 His experience in the medical technology field is complemented by his previous roles at Novian Health, where he has been instrumental in bringing innovative solutions to market.

He actively participates in industry events, such as the LSI USA Emerging Medtech Summit, where he discusses the impact of Novian Health's technologies on breast cancer treatment, emphasizing the benefits of minimally invasive procedures compared to traditional surgeries.14 Chip Appelbaum is based in the Greater Chicago Area and has built a professional network of over 500 connections on LinkedIn.2